Castle Share Price

Castle Share Price

NASDAQ: CSTL | Small Cap | Healthcare
$32.91
-$0.38 (-1.14%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Castle Stock Performance

Open
$32.81
Prev. Close
$33.30
Circuit Range
N/A
Day Range
$32.53 - $33.22
Year Range
$17.84 - $44.13
Volume
11,234
Average Traded
$32.79

Castle Share Price Today

As of 21 November 2026, Castle Biosciences, Inc.'s share price is $32.91. The stock opened at $32.81, compared to its previous close of $33.30. During today's trading session, Castle Biosciences, Inc.'s share price traded between $32.53 and $33.22, with an average price of $32.88. Over the past 52 weeks, the stock has recorded a high of $44.13 and a low of $17.84. In terms of performance, Castle Biosciences, Inc.'s share price has risen by 56.14% over the last six months and is down 17.28% on a year-on-year basis.

Castle Share Price Chart

Line chart of the Castle price trend over the selected period. The price fell overall, ranging from 32.53 to 33.57, ending at 32.91.
$32.53$33.22
L
Show Current Price
H

Castle Stock Fundamentals & Key Indicators

Market Cap
$954.07M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.75
Revenue (TTM)
$344.23B
Return On Equity (TTM)
-4.81%
Profit Margin
-7.02%
Debt to Equity
0.02
Quarterly Earnings Growth YoY
-75.97%

Castle Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$87.01$83.68$103.55$102.89
Net Profit-$2.33-$14.52-$2.06-$4.10
Net Profit Margin-2.68%-17.35%-1.99%-3.98%
Income ChangeN/A-523.18%85.81%-99.03%

Castle Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$137.04$219.79$332.07$344.23
Net Profit-$67.14-$57.47$18.25-$24.16
Net Profit Margin-48.99%-26.15%5.50%-7.02%
Income ChangeN/A14.40%131.76%-232.38%

Castle Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets217.46171.08157.71155.04
Current Assets361.1360.15295.64292.29
Total Assets578.56531.24453.34447.33
Non Current Liabilities39.0126.0114.412.05
Current Liabilities68.6849.3947.6736.13
Total Liabilities107.6875.462.0748.18
Shareholders' Equity470.87455.84391.27399.15

Castle Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating64.3564.87-5.63-41.66
Investing-60.37-50.14-16.18-166.55
Financing-6.966.14-2.31.52

About Castle

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

Castle Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$37.01
$32.82
-11.56%
Oct 2026
$35.98
$37.11
+4.59%
Sep 2026
$33.39
$35.48
+3.65%
Aug 2026
$27.91
$34.23
+21.99%
Jul 2026
$23.91
$28.06
+17.75%
Jun 2026
$21.02
$23.83
+13.05%
May 2026
$24.58
$21.08
-13.85%
Apr 2026
$24.89
$24.47
-0.33%
Mar 2026
$28.66
$24.55
-16.75%
Feb 2026
$39.84
$29.49
-25.11%
Jan 2026
$39.12
$39.38
+1.31%
Dec 2025
$39.70
$38.87
-2.31%

Castle Share Price FAQs